Showing: 1 - 10 of 25 RESULTS

Can Coronavirus Symptoms be Cured by Natural Medicine?



a sandwich sitting on top of a wooden table: Photo used for representationa purposes only.


© Provided by Mid-Day
Photo used for representationa purposes only.

In the last eight months of the Coronavirus pandemic, enough cases have been made for supplementing Covid-19 treatment with natural medicine. Data emerging from multiple locations has recorded a decline in mortality rates in the states and countries that have incorporated natural medicine for immune boosting and to aid from Covid-19.

China was among the first to set this trend as the Chinese Government mandated the use of traditional Chinese medicine (TCM) for Coronavirus treatment in February 2020. Later, a trend was observed when Madagascar created and mandated the use of COVID Organics with anti-malarial herb Artemisia.

India witnessed a severe outbreak from March-April, and the states of Kerala and Goa announced to incorporate Ayurveda for immune boosting and as an adjunct treatment of Covid-19. Industry estimates show that the states continue to have one of the lowest coronavirus related death rates in India, which are close to one-tenth of their neighbouring states, shares Biogetica, a pharma company that combines ayurveda, allopathy and homeopathy in its medicines.

As per initial investigations done by doctors, it was pointed that there wasn’t enough scientific data or studies done to support the usage of natural medicine. However, the trends indicate many lives have been saved and the legislators across the world should consider this option strongly along with an increase in coronavirus testing, it added.

“Most studies done on herbal or homeopathic medicine for coronavirus thus far are either in silica, in vitro, adjunct or preventative. Numerous positive outcomes have been noticed. One prime example is a German In vitro study done by Max Planck Institute that showed Artemisia extracts breaking the bond between the virus and infected cells. However, none of these studies has compared natural treatment to pharmaceutical treatment of Coronavirus directly. At most they have given natural treatment as an add on and noticed some slight improvement in the patients receiving both treatments simultaneously.”

Corival Life Sciences, a joint venture between Biogetica and Wockhardt Foundation, has now conducted a trial where Immunofree and Reginmune, its Ayurvedic and nutraceutical products are being studied as the main medicine for half the patients in the trial. Corival Life Sciences last month launched a CTRI registered, multicentre, randomized clinical trial. Half the patients were put on Reginmune and Immunofree while the other half in the control arm were given the Govt SOP of HCQ, Favipiravir Azithromycin and Cetirizine, the pharma company said.

“Immunofree, an Ayurvedic medicine contains 15 herbs including Artemisia, Giloy, Glycyrrhiza, Andrographis, Haritaki and others recommended by AYUSH and is being used in countries who have mandated natural treatment of Corona. Regimmune is a western immune modulator with Vitamins, Minerals and Amino Acids.

“The interim report of the trial makes a ground-breaking revelation. Patients on only Immunofree and Reginmune resolved coronavirus symptoms faster and 86 per cent of them tested negative for Coronavirus in five days. In comparison most symptoms lasted longer on the pharmaceutical SOP and only 60 per cent tested

COVID-19 antibodies last at least three months; so do symptoms for many

(Reuters) – The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

FILE PHOTO: Convalescent plasma samples in vials are seen before being tested for COVID-19 antibodies at the Bloodworks Northwest Laboratory during the coronavirus disease (COVID-19) outbreak in Renton, Washington, U.S. September 9, 2020. REUTERS/Lindsey Wasson

COVID-19 antibodies last at least three months

People infected with COVID-19 develop antibodies targeting the new coronavirus that last for at least three months, according to two reports published on Thursday in Science Immunology. The two studies, together involving nearly 750 patients, both point to immunoglobulin G (IgG) antibodies, which start showing up well after an infection begins, as the longest-lasting. Researchers found IgG antibodies with two targets – a spike protein on the virus that helps it infect cells, and a part of the spike called the receptor binding domain (RBD) – lasted more than 100 days. While the protective effect of COVID-19 antibodies is not completely clear, Jen Gommerman of the University of Toronto, coauthor of the study, said her team also found levels of so-called neutralizing antibodies, which inactivate the virus, “appeared to be very stable.” The other study, from Harvard Medical School, reported similar findings. This means that a properly designed vaccine “should elicit a durable antibody response that has the potential to neutralize the virus,” Gommerman said. Her group also found that antibodies in saliva correlated with antibodies in blood, but at this point the saliva tests are not sensitive enough to replace blood tests. (bit.ly/2GSo5Id; bit.ly/33NEOFE)

COVID-19 symptoms linger for months for many

Three months after becoming ill, many COVID-19 patients still have symptoms, two studies confirm, and the more severe the initial infections, the higher the odds of persistent problems. In Spain, doctors checked back with 108 patients, including 44 who had been severely ill. At 12 weeks after diagnosis, 76% still reported after-effects, with 40% reporting three or more coronavirus-related health issues, doctors said in a paper posted on Thursday on medRxiv ahead of peer review. The most common complaints were shortness of breath, physical weakness, cough, chest pain, palpitations, and psychological and cognitive disorders. In a similar study of 233 U.S. COVID-19 patients – eight of whom had been severely ill – one in four still had symptoms 90 days after first feeling ill. Rates were higher for patients who had been sicker: 59.4% at 30 days and 40.6% at 90 days. “But even for very mild and initially asymptomatic cases, 14.3% have complications persist for 30 days or longer,” the authors reported on Sunday on medRxiv. In the U.S. study, the most common persistent symptoms were impaired smell and taste, difficulty concentrating, shortness of breath, memory loss, confusion, headache, heart palpitations, chest pain, pain with deep breaths, dizziness, and rapid heartbeat. (bit.ly/3iPD2rN; bit.ly/2SKk0IK)

Remdesivir cut COVID-19 recovery time by 5 days

Final data from a large study of Gilead Sciences Inc’s GILD.O

Prodrugs Infusion Beats Oral PD Therapy for Motor Symptoms

A 24-hour continuous subcutaneous infusion of foslevodopa/foscarbidopa improved Parkinson’s disease (PD) motor symptoms during all waking hours for patients with advanced disease, according to a new study.

The beneficial effects of these phosphate prodrugs of levodopa and carbidopa were most noticeable in the early morning, results of the phase 1B study showed.

As PD progresses and dosing of oral levodopa/carbidopa (LD/CD) increases, its therapeutic window narrows, resulting in troublesome dyskinesia at peak drug levels and tremors and rigidity when levels fall.

“Foslevodopa/foscarbidopa shows lower OFF time than oral levodopa/carbidopa, and this was statistically significant. Also, foslevodopa/foscarbidopa (fosL/fosC) showed more ON time without dyskinesia compared to oral levodopa/carbidopa. This was also statistically significant,” lead author Sven Stodtmann, PhD, of AbbVie GmbH & Company KG, Ludwigshafen, Germany, reported in his recorded presentation at the Movement Disorders Society’s 23rd International Congress of Parkinson’s Disease and Movement Disorder (Virtual) 2020.

The analysis included 20 patients, and all data from these individuals were collected between 4:30 AM and 9:30 PM.

Participants were 12 men and 8 women, aged 30 to 80 years, with advanced, idiopathic PD responsive to levodopa but inadequately controlled on their current stable therapy, having a minimum of 2.5 OFF hours/day. Mean age was 61.3 ± 10.5 years (range 35-77 years).

In this single arm, open-label study, they received subcutaneous infusions of personalized therapeutic doses of fosL/fosC 24 hours/day for 28 days after a 10- to 30-day screening period during which they recorded LD/CD doses in a diary and had motor symptoms monitored using a wearable device.

Following the screening period, fosL/fosC doses were titrated over up to 5 days, with subsequent weekly study visits, for a total time on fosL/fosC of 28 days. Drug titration was aimed at maximizing functional ON time and minimizing the number of OFF episodes while minimizing troublesome dyskinesia.

Continuous infusion of fosL/fosC performed better than oral LD/CD on all counts.

“The OFF time is much lower in the morning for people on foslevodopa/foscarbidopa [compared with oral LD/CD] because this is a 24-hour infusion product,” Stodtmann explained.

The effect was maintained over the course of the day with little fluctuation with fosL/fosC, OFF periods never exceeding about 25% between 4:30 AM and 9 PM. For LD/CD, OFF periods were highest in the early morning and peaked at about 50% on a 3- to 4-hour cycle during the course of the day.

Increased ON time without dyskinesia varied between about 60% and 80% during the day with fosL/fosC, showing the greatest difference between fosL/fosC and oral LD/CD in the early morning hours.

“ON time with nontroublesome dyskinesia was lower for foscarbidopa/foslevodopa compared to oral levodopa/carbidopa, but this was not statistically significant,” Stodtmann said. ON time with troublesome dyskinesia followed the same pattern, again, not statistically significant.

Looking at the data another way, the investigators calculated the odds ratios of motor symptoms using fosL/fosC compared with oral LD/CD. Use of fosL/fosC was associated with a 59% lower risk of being in the OFF state during the day compared with

The Keto Diet Might Be Worth A Shot If You’re Dealing With PCOS Symptoms

From Women’s Health

Having polycystic ovary syndrome (PCOS) can affect a lot of different areas of your life. Among other things, PCOS can impact your weight, and a lot of questions come up about the best way to manage PCOS weight gain via your diet. One frequently searched query? Whether the keto diet is a good eating method to help manage PCOS weight gain and other symptoms.

Before we get into that, it’s important to go over some PCOS basics. PCOS is a health condition caused by an imbalance of reproductive hormones, according to the U.S. Department of Health & Human Services’ Office on Women’s Health (OWH). This hormone imbalance causes problems in the ovaries, which make an egg that’s released each month as part of your menstrual cycle. When you have PCOS, the egg might not develop the way it should, or it might not be released during ovulation, according to the OWH.

PCOS can cause a range of symptoms, including irregular periods, infertility, excess hair growth, severe acne, and weight gain, per the American College of Obstetricians and Gynecologists (ACOG). As many as four in five women with PCOS deal with weight issues in conjunction with the condition, ACOG says.

PCOS may be managed with medical interventions like hormonal birth control pills. But lifestyle management, like losing even a little weight, may also help alleviate symptoms, according to ACOG.

And that’s where the keto diet question comes up a lot. Here’s what you need to know about how the keto diet can impact PCOS symptoms.

Is following the keto diet beneficial if you have PCOS?

There’s a lot to dig into here. People with PCOS often deal with insulin resistance, according to the Centers for Disease Control and Prevention (CDC). This means that the body can make insulin, which helps blood sugar enter the body’s cells to provide energy, but can’t use it effectively. Insulin resistance increases the risk of developing type 2 diabetes. Insulin resistance can also lead to patches of thickened, velvety, darkened skin, a condition known as acanthosis nigricans, and this commonly occurs with PCOS, per ACOG.

So, how does the keto diet factor in here? The keto diet is an eating plan that focuses on minimizing your carbs and increasing your fat intake to get your body to use fat as a form of energy. People on the keto diet usually have no more than 50 grams of carbs a day, but some keto fans aim to have no more than 20 grams a day.

As you may (or may not) know, carbs convert into glucose (sugar) in the body, and insulin is needed to take that sugar to your cells for energy. Limiting your carb intake—like you would on the keto diet—can help relieve the insulin resistance that can occur as a result of having PCOS, but likely only for the short term, says Scott Keatley, RD, of Keatley Medical Nutrition Therapy. However, building lean body mass (read: muscle) and losing

Over 80% of coronavirus cases lack ‘core’ symptoms when tested: study

Estimates of asymptomatic coronavirus cases are around 40-45% according to Dr. Anthony Fauci, with the World Health Organization previously projecting a similar estimate, though a new study suggests silent spreaders could comprise more than three-quarters of cases.

Researchers from University College London published their peer-reviewed findings on Thursday in Clinical Epidemiology.

“Little is known about what proportion of infectious people are asymptomatic and potential ‘silent’ transmitters,” study authors wrote. They used data from the Office for National Statistics Coronavirus (COVID-19) Infection Survey pilot study, which surveys households in England.

Up to 86% of infected individuals reported no symptoms specific to COVID-19 when they were tested, per the study. (iStock)

Up to 86% of infected individuals reported no symptoms specific to COVID-19 when they were tested, per the study. (iStock)

UCLA NEW $10 COVID TEST CAN PROCESS THOUSANDS OF RESULTS IN A DAY

Of 36,061 people who were tested between April 26 and June 27, 625 (1.7%) reported symptoms on the day of the test. Of the total, just 115 people tested positive, and of those, 76.5% reported no symptoms when they were tested, while 86% listed no symptoms specific to COVID-19.

The study focused on “core” symptoms like cough, fever and loss of taste or smell.

Researchers said the findings suggest that symptom-based testing will not fully capture silent, or asymptomatic, transmission, and “our analyses suggest that asymptomatic cases of COVID-19 were widespread in the UK in Spring 2020.”

They called for a change in future testing strategies to prevent future outbreaks and advised frequent, widespread testing regardless of symptoms. They said this could be possible by developing “simpler tests that produce rapid results at low cost, accepting some loss of sensitivity.”

Nevertheless, the Centers for Disease Control and Prevention (CDC) advises confirming results from rapid tests with a more sensitive test like an RT-PCR/nasal swab. The agency also advises 14-day self-quarantine following exposure or travel, even if virus tests return negative.

CLICK HERE FOR THE FOX NEWS APP

Source Article

No symptoms for 86% of lockdown COVID cases, UK study says

LONDON (Reuters) – People who were asymptomatic accounted for 86% of the people who tested positive for COVID-19 in a UK sample population during lockdown, a study showed on Thursday, meaning the current policy of testing people with symptoms might miss many cases.

In England, people are encouraged to get tested for COVID-19 only if they have symptoms of a persistent cough, fever, or loss of taste or smell, with suspected contacts of positive cases told to self-isolate in the first instance.

But epidemiologists at University College London found that such an approach might miss the vast majority of cases, complicating Prime Minister Boris Johnson’s attempts to clamp down on a second wave of the virus.

UCL scientists used the Office for National Statistics Infection Survey, which looks at the prevalence of COVID-19 in the community and not only those who get a test because they have symptoms.

The pilot study sampled 36,061 people living in England, Wales and Northern Ireland who were tested between April 26 and June 27.

Of the 115 with a positive result, only 16 reported symptoms, with 99 not reporting any specific symptoms on the day of the test. Moreover, 142 people who reported symptoms on the day of the test did not test positive for COVID-19, vastly outnumbering those who tested positive.

“The fact that so many people who tested positive were asymptomatic on the day of a positive test result calls for a change to future testing strategies,” said Irene Petersen of UCL Epidemiology & Health Care.

“More widespread testing will help to capture ‘silent’ transmission and potentially prevent future outbreaks.”

The authors noted that other studies showed different results, with one in China suggesting just 5% of cases were asymptomatic, and a study in Iceland suggesting 43 cases out of 100 had no symptoms. They added that the sampling used in any study was likely to be a factor in its findings.

(Reporting by Alistair Smout; editing by Michael Holden)

Source Article

More than 80% of people with coronavirus had no symptoms: UK study

Local residents and visitors shop in Peascod Street on 27th August 2020 in Windsor, United Kingdom.

Mark Kerrison | In Pictures | Getty Images

So-called “silent spreaders” of the coronavirus could be more common than previously thought, with a U.K. study finding that more than two thirds of people who tested positive for the virus were asymptomatic on the day they took a test.

University College London researchers studied data collected by U.K. statistics body, the Office for National Statistics, which has been regularly collecting coronavirus testing data from thousands of British households during the pandemic as part of its “infection survey.” The survey tests households whether they have symptoms or not.

The study, which was peer reviewed, looked at 36,061 individuals who took a coronavirus test as part of the infection survey between 26 April and 27 June 2020. It found that 86.1% of those who tested positive for the virus did not report “core” symptoms associated with the virus (a cough, fever or a loss of taste and/or smell) on the day they took a test. Out of the 115 people that received a positive coronavirus result, only 16 reported the main symptoms that we associate with the virus.

Researchers Irene Petersen and Andrew Phillips concluded in the study, published in the Clinical Epidemiology journal on Thursday, that “Covid-19 symptoms are poor markers of SARS-CoV-2 (the new coronavirus).”

“To reduce transmission of SARS-CoV-2, it is important to identify those who are infectious. However, little is known about what proportion of infectious people are asymptomatic and potential “silent” transmitters,” the researchers noted.

The results of the study showed that “a more widespread testing programme is necessary to capture ‘silent’ transmission and potentially prevent and reduce future outbreaks,” they argued.

Testing regimes have had mixed success in Europe. While Germany has been praised for its extensive testing program and track and trace system to contain outbreaks, the U.K. took a while to ramp up widespread testing, and has been under pressure from a rapid increase in demand for tests, and delays in processing.

The launch of the U.K.’s track and trace app was also delayed and the government most recently came under fire when it emerged that it had “missed” thousands of positive cases due to a data blunder.

Source Article

Symptoms of Anxiety Have Doubled in the United States Since Start of COVID-19

Kantar Health finds that 46% of patients have cancelled scheduled appointments, leaving healthcare providers to seek other methods to reach Americans

Ahead of World Mental Health day on 10th October, Kantar Health, a leading global healthcare data, analytics and research provider, today announced that symptoms related to anxiety have doubled in the United States since the start of the COVID-19 pandemic, leading to a significant change in attitudes and behaviors of those impacted.

These findings are from Kantar Health’s National Health and Wellness Survey, the largest patient-reported outcomes survey in the world. Kantar Health revealed these findings in a recent episode of Health Heroes, a podcast series aimed to inform and educate life sciences companies on ways to get closer to patients to help drive improved health outcomes.

A ‘sobering’ mental health situation

Symptoms of anxiety can vary, as some patients reported change in sleep or the inability to care for themselves, while others reported forgoing scheduled appointments with their doctor or skipping doses of their medication.

Prior to the pandemic, America had a shortage in psychologists, psychiatrists, behavioral therapists and counselors. Now, with more Americans reporting symptoms related to anxiety, this gap has only been further exacerbated as mental health professionals struggled to meet the demands of the American public.

As such, there needs to be a workforce readjustment and more resources need to be made available for training of mental health professionals to meet the current and future anticipated challenges.

As a result, this will require a multi-year strategy, leaving a gap in the ability to deliver mental health services in the immediate future. To help in the short-term, it is essential that healthcare providers maintain communication with those that are most vulnerable to mental health issues and ensure that they are getting necessary treatment for their symptoms.

“COVID-19 has shined a glaring light on the inequities, disparities and poor funding of the US public health system,” stated Dr. David Nash of Thomas Jefferson University. “Despite this, I am optimistic about the future of the US health care system as it provides us with a once in a century opportunity to self-reflect and make the appropriate changes needed to make our system better and safer for all Americans.”

Kantar Health found that 46% of patients cancelled or delayed their appointments due to COVID-19, with 26% of those cancelling their appointment due to worries around contracting the virus. This can lead to worsening symptoms of chronic illness and increase mental health issues.

To reach patients who have decided to forego their regular appointments, Kantar Health suggests that doctors need to find ways to maintain regular communication with them, such as through the use of telehealth or in-home care. In order to treat these patients, doctors need to promote a “back to prevention” mindset. In this scenario, doctors encourage their patients to resume preventative measures such as mammograms and screenings along with monitoring of chronic illnesses, such as diabetes and hypertension.

“Healthcare providers need to proactively

Newlywed, mom ‘COVID long haulers’ battle debilitating symptoms months later

Doctors say they’re bracing for a “tsunami” of “COVID long haulers”

As the coronavirus pandemic continues across the U.S., experts are noticing another wave of the pandemic with what they’re calling “COVID long-haulers,” or people suffering debilitating symptoms months after having the coronavirus.

Doctors say they are seeing many people who have recovered from COVID but are finding themselves still not well.

Caitlin Barber, a 27-year-old newlywed, is one of these “COVID long haulers,” who led a healthy lifestyle with her husband and spent time training as a runner. She was also a dietician at a nursing home.

Caitlin Barber poses for a photo after a marathon.

Caitlin Barber poses for a photo after a marathon.

Caitlin Barber poses for a photo after a marathon.

“We were living the newlywed dream, you know and loving life,” Barber told “Good Morning America.”

In March, things changed instantly when she was diagnosed with COVID-19. Barber recovered from the disease, but getting rid of the virus wouldn’t be the end of it.

Seven months after getting COVID, Barber said that the side effects of the disease have lingered, affecting her ability to walk on her own and even do simple tasks like showering.

“We kind of call it the Corona Coaster because one day could be okay, and the next day I’m on the floor, having convulsions, thinking I’m having a heart attack,” said Barber.

Michaelene Carlton, a mom of two from Delaware, has also been struggling since recovering from COVID-19. Some of the symptoms she’s been experiencing are extreme headaches.

“A bad day is some days me not being able to get out of bed,” Carlton told “GMA.” “The headaches are so extreme that I’m taking migraine medicine and sleeping for 14 to 16 hours a day.”

Because of how bad their symptoms were getting, both women sought help online among a community of people experiencing the same thing after recovering from COVID-19. It was in the Facebook support group SurvivorCorps that each learned about Mount Sinai’s post-COVID clinic — the largest clinic in the country dedicated to treating long haulers.

“What we’re seeing at the center is a very wide distribution of both age, sex, ethnicity, preexisting conditions versus healthy patients,” said Dr. Zijian Chen, director of Mount Sinai’s post COVID clinic. “You’re not protected if you’re young and healthy, unfortunately.”

At Mount Sinai, they’re experiencing an influx of patients who are turning to them for help, and the waitlist is growing.

“I have patients not only across the country, but across the world that are seeking advice because they just haven’t been able to find the support in terms of the healthcare system,” said Mount Sinai’s Dr. Dayna McCarthy.

Chen also warned that the growing number of people experiencing COVID long hauler symptoms may have major consequences down the line.

“This other group of patients with symptoms are unrelenting that need to see many

Early school sports reduce ADHD symptoms for girls in later years

Girls who played after-school sports in elementary school seem to have fewer symptoms of attention-deficit/hyperactivity disorder once they reach middle school, a new study suggests.

The research included both boys and girls, but the effect of sports on attention and behavior symptoms was only significant in girls.

“Girls, in particular, benefit from participation in sport when it comes to ADHD symptoms,” said lead author Linda Pagani. She’s a professor at the University of Montreal School of Psychoeducation in Quebec, Canada.

ADHD is a condition that includes ongoing patterns of inattention, hyperactivity and/or impulsivity — issues that interfere with a person’s functioning or development, according to the U.S. National Institute of Mental Health.

ADHD signs and symptoms include: Making careless mistakes in schoolwork, at work or during other activities; having difficulty paying attention in tasks like a lecture or lengthy reading assignment or during play; seeming not to listen when spoken to directly; interrupting others; fidgeting; leaving one’s seat when staying seated is expected; running around in inappropriate situations or feeling restless, in teens and adults.

The current study included nearly 1,500 children born in Quebec in 1997 and 1998. The group included 758 girls and 733 boys with complete data from age 6.

Parents were asked if kids participated in an extra-curricular physical activity with a coach or instructor between the ages of 6 and 10.

When kids were 12, teachers were asked to compare their ADHD symptoms and behaviors to their peers’. Teachers only looked for symptoms suggestive of ADHD, not a formal diagnosis, Pagani said.

Girls who consistently participated in organized sports were less likely to have ADHD symptoms than girls who didn’t, the study found. The researchers didn’t find a similar link for boys.

Pagani said organized sports likely help reduce ADHD symptoms in several ways: During an organized physical activity, kids have to listen and focus on what their coach is saying. It’s different from an unstructured after-school program where kids can do whatever they want.

Sports also help inhibit distraction and promote planning behavior, Pagani explained. Plus, sports get kids away from their screens and switching from one app to the next, and give them a chance to shake off some energy.

So, why wouldn’t sports make a difference for boys, too?

They probably do, Pagani said, but the upside wasn’t strong enough to be statistically significant.

“Boys are over-identified when it comes to any kind of ADHD symptoms,” she said. “For every three boys with ADHD, only one girl will get identified. Girls may not be getting pharmacology [medications] and psychotherapy that boys often do. In this particular domain, because girls are under-identified and under-treated, they tend to benefit a lot from sports.”

All kids — both girls and boys — can benefit from taking part in organized sports, Pagani said.

Dr. Andrew Adesman, chief of developmental and behavioral pediatrics at Cohen Children’s Medical Center in New Hyde Park, N.Y., reviewed the findings.

“Although the researchers found an association in girls between organized sports